3-Chloro-4-(3-fluorobenzyloxy)aniline CAS:202197-26-0
3-Chloro-4-(3-fluorobenzyloxy)aniline, often referred to by its chemical abbreviation, serves various biomedical purposes due to its pharmacological properties and potential therapeutic benefits. 1. Drug Development: This compound is actively studied for its potential in drug development. Researchers explore its chemical modifications to enhance efficacy and reduce potential side effects. The goal is to develop new pharmaceuticals with improved therapeutic outcomes for various medical conditions. 2. Antimicrobial Properties: 3-Chloro-4-(3-fluorobenzyloxy)aniline exhibits antimicrobial activity against bacterial pathogens. Studies focus on elucidating its mechanism of action and evaluating its efficacy against drug-resistant strains. This makes it a candidate for developing new antimicrobial therapies to combat emerging infectious diseases. 3. Anti-Inflammatory Potential: Researchers are investigating the compound's anti-inflammatory properties. It shows promise in modulating inflammatory responses and pathways, potentially offering treatments for conditions like arthritis and inflammatory bowel diseases. By reducing inflammation, it may alleviate symptoms and improve patient outcomes. 4. Oncology Research: Preliminary studies suggest potential applications in oncology. Researchers are exploring its cytotoxic effects on cancer cells and mechanisms of action. This selective cytotoxicity against cancerous cells while sparing healthy tissues is crucial for developing safer and more effective cancer treatments. 5. Neuroprotective Effects: Research indicates potential neuroprotective properties of the compound. Studies focus on its ability to protect neurons and mitigate inflammation in neurological disorders such as Alzheimer's and Parkinson's diseases. This research opens avenues for novel therapeutic interventions in neurodegenerative conditions. In summary, 3-Chloro-4-(3-fluorobenzyloxy)aniline holds promise in drug development, antimicrobial therapy, anti-inflammatory treatments, oncology research, and potential neuroprotective applications. Ongoing research aims to fully explore its therapeutic potential across various medical fields, paving the way for innovative treatments and improved patient care.
Composition | C13H11ClFNO |
Assay | 99% |
Appearance | white powder |
CAS No. | 202197-26-0 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |